Inhibition of transforming growth factor-β/Smad signaling by phosphatidylinositol 3-kinase pathway

Cancer Letters

Volumn 242, Issue 2, 2006, Pages 207-214

  Qiao, Jingbo ^a   Kang, Junghee ^a   Ko, Tien C ^a,b   Evers, B Mark ^a,b   Chung, Dai H ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

GRP; Neuroblastoma; PI3 K; Smad; TGF

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GASTRIN RELEASING PEPTIDE; LUCIFERASE; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN P85; PROTEIN SUBUNIT; SMAD PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BINDING AFFINITY; CANCER GROWTH; CELL GROWTH; CELL NUCLEUS; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL PROLIFERATION; CHROMONES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGANDS; MORPHOLINES; MUTATION; NEUROBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; SMAD PROTEINS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 33749250715     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.11.007     Document Type: Article

References (31)

1. Maris J.M., and Matthay K.K. Molecular biology of neuroblastoma. J. Clin. Oncol. 17 (1999) 2264-2279
2. Kim S., Hu W., Kelly D.R., Hellmich M.R., Evers B.M., and Chung D.H. Gastrin-releasing peptide is a growth factor for human neuroblastomas. Ann. Surg. 235 (2002) 621-629 (discussion 629-630)
3. Aguayo S.M., Miller Y., Boose D., Holley M., Portanova L.B., Schuyler K.D., et al. Nonconstitutive expression of the gastrin-releasing peptide autocrine growth system in human small cell lung carcinoma NCI-H345 cells. Cell Growth Differ. 7 (1996) 563-572
4. Hajri A., Balboni G., Koenig M., Garaud J.C., and Damge C. Gastrin-releasing peptide: in vivo and in vitro growth effects on an acinar pancreatic carcinoma. Cancer Res. 52 (1992) 3726-3732
5. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
6. Chang F., Lee J.T., Navolanic P.M., Steelman L.S., Shelton J.G., Blalock W.L., et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17 (2003) 590-603
7. Qiao J., Kang J., Cree J., Evers B.M., and Chung D.H. Gastrin-releasing peptide-induced down-regulation of tumor suppressor protein PTEN (phosphatase and tensin homolog deleted on chromosome ten) in neuroblastomas. Ann. Surg. 241 (2005) 684-691 (discussion 691-682)
8. de Caestecker M.P., Piek E., and Roberts A.B. Role of transforming growth factor-beta signaling in cancer. J. Natl Cancer Inst. 92 (2000) 1388-1402
9. Massague J., and Wotton D. Transcriptional control by the TGF-beta/smad signaling system. Eur. Mol. Biol. Org. J. 19 (2000) 1745-1754
10. Attisano L., and Wrana J.L. Signal transduction by the TGF-beta superfamily. Science 296 (2002) 1646-1647
11. Hall M.C., Young D.A., Waters J.G., Rowan A.D., Chantry A., Edwards D.R., et al. The comparative role of activator protein 1 and smad factors in the regulation of timp-1 and MMP-1 gene expression by transforming growth factor-beta 1. J. Biol. Chem. 278 (2003) 10304-10313
12. Miyazono K., ten Dijke P., and Heldin C.H. TGF-beta signaling by smad proteins. Adv. Immunol. 75 (2000) 115-157
13. Inman G.J., and Hill C.S. Stoichiometry of active smad-transcription factor complexes on DNA. J. Biol. Chem. 277 (2002) 51008-51016
14. Wu L., Wu Y., Gathings B., Wan M., Li X., Grizzle W., et al. Smad4 as a transcription corepressor for estrogen receptor alpha. J. Biol. Chem. 278 (2003) 15192-15200
15. Attisano L., and Wrana J.L. Smads as transcriptional co-modulators. Curr. Opin. Cell Biol. 12 (2000) 235-243
16. Wotton D., and Massague J. Smad transcriptional corepressors in TGF beta family signaling. Curr. Top. Microbiol. Immunol. 254 (2001) 145-164
17. Zhang Y., and Derynck R. Regulation of smad signalling by protein associations and signalling crosstalk. Trends Cell Biol. 9 (1999) 274-279
18. Piek E., and Roberts A.B. Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis. Adv. Cancer Res. 83 (2001) 1-54
19. Jonson T., Albrechtsson E., Axelson J., Heidenblad M., Gorunova L., Johansson B., et al. Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas. Int. J. Oncol. 19 (2001) 71-81
20. Jonson T., Gorunova L., Dawiskiba S., Andren-Sandberg A., Stenman G., ten Dijke P., et al. Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer. Genes Chromosom. Cancer 24 (1999) 62-71
21. Ten Dijke P., Goumans M.J., Itoh F., and Itoh S. Regulation of cell proliferation by smad proteins. J. Cell. Physiol. 191 (2002) 1-16
22. He C., and Chen X. Transcription regulation of the vegf gene by the BMP/smad pathway in the angioblast of zebrafish embryos. Biochem. Biophys. Res. Commun. 329 (2005) 324-330
23. Vanhaesebroeck B., and Waterfield M.D. Signaling by distinct classes of phosphoinositide 3-kinases. Exp. Cell Res. 253 (1999) 239-254
24. Sumitomo M., Milowsky M.I., Shen R., Navarro D., Dai J., Asano T., et al. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway. Cancer Res. 61 (2001) 3294-3298
25. Derynck R., Zhang Y., and Feng X.H. Smads: transcriptional activators of TGF-beta responses. Cell 95 (1998) 737-740
26. Bakin A.V., Tomlinson A.K., Bhowmick N.A., Moses H.L., and Arteaga C.L. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275 (2000) 36803-36810
27. Song K., Cornelius S.C., Reiss M., and Danielpour D. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of smad3 but not smad2. J. Biol. Chem. 278 (2003) 38342-38351
28. Remy I., Montmarquette A., and Michnick S.W. PKB/Akt modulates TGF-beta signalling through a direct interaction with smad3. Nat. Cell Biol. 6 (2004) 358-365
29. Bhowmick N.A., Zent R., Ghiassi M., McDonnell M., and Moses H.L. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J. Biol. Chem. 276 (2001) 46707-46713
30. Mulder K.M. Role of ras and mapks in TGFbeta signaling. Cytokine Growth Factor Rev. 11 (2000) 23-35
31. Xiao Y.Q., Malcolm K., Worthen G.S., Gardai S., Schiemann W.P., Fadok V.A., et al. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. J. Biol. Chem. 277 (2002) 14884-14893